Filtros de búsqueda

Lista de obras de Maya Hema Buch

03.24 Effect of tocilizumab therapy on il-6 signalling pathway in early rheumatoid arthritis patients

scholarly article published March 2017

A Multicenter Study of the Validity and Reliability of Responses to Hand Cold Challenge as Measured by Laser Speckle Contrast Imaging and Thermography: Outcome Measures for Systemic Sclerosis-Related Raynaud's Phenomenon. ⬇️

artículo científico publicado en 2018

A prospective, single-centre, randomised study evaluating the clinical, imaging and immunological depth of remission achieved by very early versus delayed Etanercept in patients with Rheumatoid Arthritis (VEDERA). ⬇️

artículo científico publicado en 2016

A randomised controlled trial of etanercept and methotrexate to induce remission in early inflammatory arthritis: the EMPIRE trial

artículo científico publicado en 2014

A randomised double-blind placebo-controlled 12- week feasibility trial of methotrexate added to treatment as usual in early schizophrenia: study protocol for a randomised controlled trial

artículo científico publicado en 2015

A2.40 Investigating IL-6 pathway signalling kinetics in peripheral blood single cell subsets with tocilizumab therapy in patients with early rheumatoid arthritis ⬇️

scholarly article by L Ouboussad et al published February 2016 in Annals of the Rheumatic Diseases

Abatacept in the treatment of rheumatoid arthritis

artículo científico publicado en 2008

Abatacept or tocilizumab after rituximab in rheumatoid arthritis? An exploratory study suggests non-response to rituximab is associated with persistently high IL-6 and better clinical response to IL-6 blocking therapy

artículo científico publicado en 2014

Abatacept reduces disease activity and ultrasound power Doppler in ACPA-negative undifferentiated arthritis: a proof-of-concept clinical and imaging study ⬇️

artículo científico publicado en 2016

Abnormal electrophysiological testing associates with future incidental significant arrhythmia in scleroderma

artículo científico publicado en 2020

Abnormal left ventricular geometry is prevalent in asymptomatic patients with established rheumatoid arthritis compared with those with early disease and healthy controls

artículo científico publicado en 2015

Absence of Scleroderma pattern at nail fold capillaroscopy valuable in the exclusion of Scleroderma in unselected patients with Raynaud's Phenomenon ⬇️

artículo científico publicado en 2016

Access to the next wave of biologic therapies (Abatacept and Tocilizumab) for the treatment of rheumatoid arthritis in England and Wales: addressing treatment outside the current NICE guidance

artículo científico publicado en 2012

Acetylcarnitine and free carnitine in body fluids before and after birth

artículo científico publicado el 1 de enero de 1979

After treat-to-target: can a targeted ultrasound initiative improve RA outcomes?

artículo científico

After treat-to-target: can a targeted ultrasound initiative improve RA outcomes?

artículo científico publicado en 2012

Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCT ⬇️

scholarly article by Sarah Brown et al published June 2018 in Health Technology Assessment

An extra dose of rituximab improves clinical response in rheumatoid arthritis patients with initial incomplete B cell depletion: a randomised controlled trial

artículo científico publicado en 2014

Anti-TNF treatment in rheumatoid arthritis

artículo científico

B Cell Therapies, Approved and Emerging: a Review of Infectious Risk and Prevention During Use. ⬇️

artículo científico

B cell biomarkers of rituximab responses in systemic lupus erythematosus

artículo científico publicado en 2011

BHPR research: qualitative * 1. Complex reasoning determines patients' perception of outcome following foot surgery in rheumatoid arhtritis

artículo científico publicado en 2012

BSR and BHPR guideline for the treatment of systemic sclerosis ⬇️

artículo científico publicado en 2016

Biologic refractory disease in rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis ⬇️

scientific article published on 06 July 2018

Biologics registers in RA: methodological aspects, current role and future applications ⬇️

artículo científico publicado en 2017

Biomarkers in the management of scleroderma: an update

scientific article published on February 2011

Can switching to abatacept therapy in patients with rheumatoid arthritis on background methotrexate reverse TNF-inhibitor-induced antinuclear autoantibody/double-stranded DNA autoantibody conversion? An analysis of the AMPLE and ATTEST trials

scientific article published on 21 August 2018

Cardiovascular effects of biological versus conventional synthetic disease-modifying antirheumatic drug therapy in treatment-naïve, early rheumatoid arthritis

artículo científico publicado en 2020

Cardiovascular outcomes of patients with rheumatoid arthritis prescribed disease modifying anti-rheumatic drugs: a review

article

Carotid artery volumetric measures associate with clinical ten-year cardiovascular (CV) risk scores and individual traditional CV risk factors in rheumatoid arthritis; a carotid-MRI feasibility study ⬇️

scholarly article by Lesley-Anne Bissell et al published 3 December 2018 in Arthritis Research and Therapy

Characterisation of sub-clinical primary myocardial disease in systemic sclerosis - preliminary findings from a cardiac magnetic resonance study

artículo científico publicado en 2014

Collagenous colitis in systemic sclerosis: an overlooked and treatable complication

artículo científico

Consensus best practice pathway of the UK Systemic Sclerosis Study group: management of cardiac disease in systemic sclerosis ⬇️

artículo científico publicado en 2017

Considerations for improving quality of care of patients with rheumatoid arthritis and associated comorbidities

artículo científico publicado en 2020

Coronary Artery Disease Evaluation in Rheumatoid Arthritis (CADERA): study protocol for a randomized controlled trial ⬇️

artículo científico publicado en 2014

Corrigendum: Synovial tissue research: a state-of-the-art review

artículo científico publicado en 2017

Costimulation blockade in rheumatic diseases: where we are?

artículo científico publicado en 2009

Creative trial design in RA: optimizing patient outcomes

artículo científico publicado en 2013

Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA.

artículo científico publicado en 2010

Defining refractory rheumatoid arthritis ⬇️

artículo científico publicado en 2018

Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology ⬇️

artículo científico publicado en 2014

Differential effects of infliximab on absolute circulating blood leucocyte counts of innate immune cells in early and late rheumatoid arthritis patients

artículo científico publicado en 2012

Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study ⬇️

artículo científico publicado en 2018

Discordance between the predictors of clinical and imaging remission in patients with early rheumatoid arthritis in clinical practice: implications for the use of ultrasound within a treatment-to-target strategy ⬇️

artículo científico publicado en 2016

Does high-dose extended course cyclophosphamide and methylprednisolone pulse therapy have a role in the management of systemic sclerosis-related interstitial lung disease? ⬇️

artículo científico publicado en 2016

Drug-Induced Interstitial Lung Disease: A Systematic Review

artículo científico publicado en 2018

Dysregulated lymphocyte proliferation and differentiation in patients with rheumatoid arthritis

artículo científico publicado en 2002

EULAR definition of difficult-to-treat rheumatoid arthritis

scientific article published on 01 October 2020

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

artículo científico publicado en 2010

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

artículo científico publicado en 2014

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

artículo científico publicado en 2020

Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis

artículo científico

Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis

artículo científico publicado en 2014

Efficacy, safety and immunogenicity of GP2015, an etanercept biosimilar, compared with the reference etanercept in patients with moderate-to-severe rheumatoid arthritis: 24-week results from the comparative phase III, randomised, double-blind EQUIRA

scholarly article by Marco Matucci-Cerinic et al published 2018 in RMD open

Efficacy, tolerability and safety of biologic therapy in rheumatoid disease: patient considerations

artículo científico publicado en 2010

European multicentre study validates enhanced liver fibrosis test as biomarker of fibrosis in systemic sclerosis

artículo científico publicado en 2019

Extracorporeal shock wave therapy in the treatment of lateral epicondylitis : a randomized multicenter trial

artículo científico publicado en 2002

FRI0130 Change in disease outcomes after implementation of treat to target, including evaluation of power doppler ultrasound remission:

FRI0130 Efficacy of A Comprehensive Cardiovascular Risk Reduction Patient Education Programme in Patients with Early Inflammatory Arthritis Following A Treat To Target Therapeutic Regime: Table 1

article by H. Inomata et al published June 2016 in Annals of the Rheumatic Diseases

FRI0334 Safety of rituximab for remission maintenance in relapsing anca–associated vasculitis: repeat cycles on clinical relapse are associated with low rates of hypogammaglobulinaemia

FcgammaRIIIA-158V and rheumatoid arthritis: a confirmation study

artículo científico publicado en 2003

First cardiovascular MRI study in individuals at risk of rheumatoid arthritis detects abnormal aortic stiffness suggesting an anti-citrullinated peptide antibody-mediated role for accelerated atherosclerosis

artículo científico publicado en 2019

Foot health needs in people with systemic sclerosis: an audit of foot health care provision

artículo científico publicado en 2011

GP2015 as a promising therapy for rheumatoid arthritis ⬇️

artículo científico publicado en 2018

Improvement in cardiovascular biomarkers sustained at 4 years following an initial treat-to-target strategy in early rheumatoid arthritis

artículo científico publicado en 2019

Improvement in insulin resistance is greater when infliximab is added to methotrexate during intensive treatment of early rheumatoid arthritis-results from the IDEA study ⬇️

artículo científico publicado en 2016

Incidental significant arrhythmia in scleroderma associates with cardiac magnetic resonance measure of fibrosis and hs-TnI and NT-proBNP.

artículo científico publicado en 2019

Induction of antinuclear antibodies in patients with rheumatoid arthritis treated with infliximab and leflunomide

artículo científico publicado en 2004

Interleukin-7 deficiency in rheumatoid arthritis: consequences for therapy-induced lymphopenia ⬇️

artículo científico publicado en 2005

Lack of response to anakinra in rheumatoid arthritis following failure of tumor necrosis factor alpha blockade

artículo científico publicado en 2004

Law of the vital few: choosing variables of disease activity in rheumatoid arthritis

artículo científico publicado en 2014

Long-term efficacy and toxicity of ciclosporin A in combination with methotrexate in poor prognosis rheumatoid arthritis

artículo científico publicado en 2009

Long-term infliximab treatment in rheumatoid arthritis: subsequent outcome of initial responders

artículo científico publicado en 2007

Management of nonresponse to rituximab in rheumatoid arthritis: predictors and outcome of re-treatment

artículo científico publicado en 2010

Mesenchymal stem cells in rheumatoid synovium: enumeration and functional assessment in relation to synovial inflammation level

artículo científico publicado en 2009

Mixed results with baricitinib in biological-resistant adult-onset Still's disease and undifferentiated systemic autoinflammatory disease

artículo científico publicado en 2020

Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: a histological, gene expression and dynamic magnetic resonance imaging pilot study

scientific article published on 04 September 2008

Multiplexing immunoassays for cytokine detection in the serum of patients with rheumatoid arthritis: lack of sensitivity and interference by rheumatoid factor.

artículo científico publicado en 2012

New therapies in the management of rheumatoid arthritis

artículo científico publicado en 2011

Newly diagnosed, treatment-naive patients with rheumatoid arthritis have early abnormalities of vascular and myocardial function

artículo científico publicado en 2015

Nonresponse to tumor necrosis factor antagonists--is there any point in re-treatment?

artículo científico publicado en 2006

Normal values and test-retest variability of stimulated-echo diffusion tensor imaging and fat fraction measurements in the muscle

scientific article published on 12 July 2019

O12 Validity of a2-component imaging-derived disease activity score (2C-DAS28) for improved assessment of synovitis in early rheumatoid arthritis ⬇️

scholarly article by Elizabeth M A Hensor et al published 1 April 2018 in Rheumatology

OP0045 Synovial B Cell Status Determines Intensity of Rituximab Therapy Required in Rheumatoid Arthritis

scholarly article by E. M. Vital et al published June 2013 in Annals of the Rheumatic Diseases

P043 Investigating IL-6 intracellular signalling in peripheral blood cell subsets in patients at early and later stages of rheumatoid arthritis (RA) ⬇️

scholarly article published 21 February 2018

Patient-reported outcomes and safety in patients undergoing synovial biopsy: comparison of ultrasound-guided needle biopsy, ultrasound-guided portal and forceps and arthroscopic-guided synovial biopsy techniques in five centres across Europe

scientific article published on 26 October 2018

Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study ⬇️

artículo científico publicado en 2018

Persistent inflammatory and non-inflammatory mechanisms in refractory rheumatoid arthritis

artículo científico publicado en 2020

Pragmatic randomised controlled trial of very early etanercept and MTX versus MTX with delayed etanercept in RA: the VEDERA trial

scientific article published on 29 January 2020

Predicting Severe Infection and Effects of Hypogammaglobulinemia During Therapy With Rituximab in Rheumatic and Musculoskeletal Diseases

artículo científico publicado en 2019

Pressure and pain in systemic sclerosis/scleroderma--an evaluation of a simple intervention (PISCES): randomised controlled trial protocol ⬇️

artículo científico publicado en 2012

Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA).

artículo científico publicado en 2013

Primary myocardial disease in scleroderma-a comprehensive review of the literature to inform the UK Systemic Sclerosis Study Group cardiac working group ⬇️

artículo científico publicado en 2016

Profiling microRNAs in individuals at risk of progression to rheumatoid arthritis ⬇️

artículo científico publicado en 2017

Re-treatment of rheumatoid arthritis patients who were initial nonresponders to rituximab: comment on the article by Thurlings et al.

artículo científico publicado en 2009

Relationship between early bone mineral density changes and long-term function and radiographic progression in rheumatoid arthritis

artículo científico publicado en 2012

Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study).

artículo científico publicado en 2013

Reporting of long-term extension studies: lack of consistency calls for consensus

artículo científico publicado en 2011

Response to 'Correspondence to viewpoint 'Defining refractory rheumatoid arthritis' by Buch' by Roodenrijs et al

scientific article published on 17 August 2018

Response to Dr Bredemeier's letter

artículo científico publicado en 2014

Response to: 'Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients' by Humby et al

scientific article published on 13 July 2019

Right drug, right patient, right time: aspiration or future promise for biologics in rheumatoid arthritis? ⬇️

artículo científico publicado en 2017

Risk of venous thromboembolism in immune-mediated inflammatory diseases: a UK matched cohort study

artículo científico publicado en 2020

SAT0011 What is Undifferentiated Arthritis (UA) in 2013, and can Progression to Rheumatoid Arthritis (RA) be Predicted?

scholarly article by S. C. Horton et al published June 2013 in Annals of the Rheumatic Diseases

SAT0049 21st century state of rheumatoid arthritis management in the uk ⬇️

scholarly article published June 2017

SAT0061 Prevalence of Co-Morbidities in Rheumatoid Arthritis (RA) and Evaluation of their Monitoring: Results of an International, Cross-Sectional Study (Comora)

artículo científico publicado en 2013

SAT0238 An Exploratory Clinical and Imaging Study Evaluating Abatacept in the Management of Poor Prognosis ACPA Negative Undifferentiated Arthritis: Table 1

article by Maya Hema Buch et al published June 2014 in Annals of the Rheumatic Diseases

SAT0359 Aligning Clinical Trials in Rheumatoid Arthritis with Real-Life Populations ⬇️

scholarly article by N.C. Navarro Coy et al published June 2015 in Annals of the Rheumatic Diseases

SAT0639 Biologic-eligible rheumatoid arthritis patients demonstrate absence of synovitis – utility of ultrasound in the management of ra-biologic population

scholarly article published June 2017

Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis

artículo científico

Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party

artículo científico publicado en 2011

Sequential use of biologic therapy in rheumatoid arthritis

artículo científico publicado en 2010

Statins do not influence clinical response and B cell depletion after rituximab treatment in rheumatoid arthritis

article

Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk test

artículo científico publicado en 2006

Sustained remission with etanercept tapering in early rheumatoid arthritis

artículo científico publicado en 2014

Synovial tissue research: a state-of-the-art review

artículo científico publicado en 2017

THU0099 Cardiovascular MR (CMR) Evidence for Reduced LV Mass in Rheumatoid Arthritis (RA), Suggesting Pathology Other than Atherosclerosis for Heart Failure: Table 1

scholarly article by L.-A. Bissell et al published June 2016 in Annals of the Rheumatic Diseases

THU0103 Synovial plasma cells predict relapse after rituximab therapy in rheumatoid arthritis

scholarly article by E. Vital et al published June 2013 in Annals of the Rheumatic Diseases

THU0114 Abatacept as an effective treatment in the management of poor prognosis ACPA negative undifferentiated arthritis

TLR dependent XBP-1 activation induces an autocrine loop in rheumatoid arthritis synoviocytes ⬇️

artículo científico publicado en 2013

The 'Switch' study protocol: a randomised-controlled trial of switching to an alternative tumour-necrosis factor (TNF)-inhibitor drug or abatacept or rituximab in patients with rheumatoid arthritis who have failed an initial TNF-inhibitor drug ⬇️

artículo científico publicado en 2014

The 2013 BSR and BHPR guideline for the use of intravenous tocilizumab in the treatment of adult patients with rheumatoid arthritis

artículo científico publicado en 2014

The 2013 BSR and BHPR guideline for the use of intravenous tocilizumab in the treatment of adult patients with rheumatoid arthritis

scholarly article by A. P. Malaviya et al published 16 September 2014 in Rheumatology

The College of Podiatry Annual Conference 2015: meeting abstracts: Harrogate, Yorkshire, UK. 19–21 November 2015. ⬇️

artículo científico publicado en 2016

The Relationship Between Synovial Pathobiology and Magnetic Resonance Imaging Abnormalities in Rheumatoid Arthritis: A Systematic Review ⬇️

artículo científico publicado en 2017

The enhanced liver fibrosis test: a clinical grade, validated serum test, biomarker of overall fibrosis in systemic sclerosis

artículo científico publicado en 2013

The impact of escalating conventional therapy in rheumatoid arthritis patients referred for anti-tumour necrosis factor-alpha therapy

artículo científico publicado en 2003

The perpetual sword of Damocles: Cardiac involvement in systemic sclerosis and the role of non-invasive imaging modalities in medical decision making

artículo científico publicado en 2020

The role of non-invasive cardiovascular imaging in the assessment of cardiovascular risk in rheumatoid arthritis: where we are and where we need to be. ⬇️

artículo científico publicado en 2016

The signalling signature downstream of the notch receptor in CD4+CD25high regulatory T cells in RA defines anergic cells: insight into resistance to anti-tumour necrosis factor therapies.

artículo científico publicado en 2005

The two facies of pyrrolizidine alkaloids: the role of the tertiary amine and its N-oxide in chemical defense of insects with acquired plant alkaloids

artículo científico publicado en 1997

The unmet need in rheumatology: reports from the Targeted Therapies meeting 2016

artículo científico publicado en 2016

The value of synovial cytokine expression in predicting the clinical response to TNF antagonist therapy (infliximab).

artículo científico publicado en 2008

The ‘therapeutic window’ and treating to target in rheumatoid arthritis ⬇️

artículo científico publicado el 1 de agosto de 2013

Time for treatment targets in rheumatoid arthritis

artículo científico publicado en 2010

To switch or not to switch after a poor response to a TNFα blocker? It is not only a matter of ACR20 OR ACR50.

artículo científico

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

artículo científico publicado en 2021

Towards an optimum strategy in rheumatoid arthritis

artículo científico publicado en 2012

Transforming clinical trials in rheumatology: towards patient-centric precision medicine

artículo científico publicado en 2020

Treating rheumatoid arthritis with tumour necrosis factor alpha blockade

artículo científico publicado en 2002

Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS). ⬇️

artículo científico publicado en 2017

True infliximab resistance in rheumatoid arthritis: a role for lymphotoxin alpha? ⬇️

artículo científico publicado en 2004

Ultrasound-detectable grey scale synovitis predicts future fulfilment of the 2010 ACR/EULAR RA classification criteria in patients with new-onset undifferentiated arthritis ⬇️

artículo científico publicado en 2017

Unmet foot health needs in people with Systemic Sclerosis: an audit of foot health care provision

article

Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis

artículo científico publicado en 2011

Validity of a two-component imaging-derived disease activity score for improved assessment of synovitis in early rheumatoid arthritis

scientific article published on 01 March 2019

What is the utility of routine ANA testing in predicting development of biological DMARD-induced lupus and vasculitis in patients with rheumatoid arthritis? Data from a single-centre cohort

artículo científico publicado en 2014

Mechanisms & management of tumour necrosis factor-blockade non-response in patients with rheumatoid arthritis

tesis doctoral

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda